This content is machine translated Blood-based analytics: clinical application “Liquid biopsy” in malignant melanoma As a biomarker for monitoring the progression of tumor diseases, the detection of tumor cell DNA in blood using next-generation sequencing (“liquid biopsy”) is becoming increasingly important. This also applies…
View Post 4 min This content is machine translated Immuno-oncology Immune checkpoint inhibitors in carcinoma patients – update for the primary care physician. Therapy with anti-PD-1, anti-PDL-1 and anti-CTLA-4 antibodies can also achieve long-term remissions in patients with previously incurable tumor diseases. Whether a carcinoma patient will respond to treatment with checkpoint inhibitors…
View Post 5 min This content is machine translated A portrait of retinoblastoma Double hit cancer With approximately one case per 15,000 to 20,000 live births, retinoblastoma is one of the rare cancers [1]. For those affected – mostly children under the age of three –…
View Post 2 min This content is machine translated Smoking Ban on tobacco advertising to protect children and young people More than a quarter of all Swiss people smoke. Although most people are aware that tobacco use can be associated with major limitations to their health. But quitting smoking is…
View Post 13 min This content is machine translated Thyroid Cancer System therapy: Current developments Targeted systemic therapies have become increasingly important in both anaplastic and advanced radioiodine-refractory differentiated thyroid carcinoma. These have proven to be effective options over the past several years in the…
View Post 3 min This content is machine translated Non-small cell lung cancer Platelets to predict immunotherapy response? Immunotherapy using checkpoint inhibitors has become an indispensable part of the treatment of non-small cell lung cancer. Nevertheless, there is room for improvement – and potential – in the area…
View Post 5 min This content is machine translated Diffuse large B-cell lymphoma (DLBCL) Innovative Salvage Therapy for Advanced DLBCL Diffuse large B-cell lymphoma is the most common type of non-Hodgkin lymphoma. If left untreated, accumulations of lymphoma cells impede the function of affected organs and lead to the death…
View Post 3 min This content is machine translated Non-small cell lung cancer Who benefits from targeted therapy? A large multicenter study led by the DKFZ-Hector Cancer Institute at the University Medical Center Mannheim confirms substantial differences in treatment response and provides important insights for treatment planning.
View Post 2 min This content is machine translated Cancer Therapy Only individualized nutrition therapy helps prevent malnutrition Low-germ diets in the treatment of cancer patients are associated with significant risks from a scientific perspective and should no longer be practiced.
View Post 9 min This content is machine translated Locally advanced/metastatic breast carcinoma 44th San Antonio Breast Cancer Symposium: Best Of From December 7-10, 2021, the 44th San Antonio Breast Cancer Symposium took place in a physical-virtual hybrid event. In a series of exciting lectures, the latest clinical and preclinical findings…
View Post 6 min This content is machine translated Gliomas New indications for immuno-oncology? While immunotherapies are rapidly gaining ground in other entities, they are still in their infancy in CNS tumors. This is due in part to the often low immunogenicity. Nevertheless, antibody-based therapies,…
